GeoVax raises ~$2.5M in registered direct offering; issues shares and warrants at $0.63

GeoVax Labs, Inc.

3,968,256 shares sold at $0.63 each with warrants to buy 11,904,768 shares at $0.63.
Gross proceeds ~$2.5M, net ~$2.325M after 7% placement agent fees.
Warrants exercisable only upon shareholder approval; expire 5 years from approval.
Roth Capital Partners acted as sole placement agent for the offering.
Proceeds to advance immunotherapies and vaccines pipeline including R&D and clinical studies.

item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.